Skip to main content
. 2022 Jan 19;12:793750. doi: 10.3389/fphar.2021.793750

TABLE 2.

The role of cannabinoid receptor ligands in regulating tumor cells and bone diseases in vitro and in vivo.

Ligand Receptor Bone tumor
Tm.Growth Osteolysis Pain
Agonists AEA CB1/CB2/GPR55/TRPV1 ↓↓ -
2-AG CB1/CB2/GPR55 -
Δ9-THC CB1/CB2 ↓↓↑↑ -
CP55,940 CB1/CB2 -
WIN55,212 CB1 ↓↓ -
HU308 CB2 ↑↓ -
JWH133 CB2 ↑↓↓ ↓↓↑
JWH139 CB2 -
JWH015 CB2 ↓↓
AM1241 CB2
Lysophosphatidyl inositol GPR55 - - -
O-1602 GPR55 - -
Antagonists AM630 CB2>CB1/GPR55 -
SR144528 CB2>CB1 - -
AM251 CB1>CB2/GPR55 - -
SR141716A CB1>CB2 - -
Cannabidiol GPR55 ↓↓ -

Abbreviations: CB1, cannabinoid type 1 receptor; CB2, cannabinoid type 2 receptor; GPR55, G protein-coupled receptor 55; TRPV1, transient receptor potential vanilloid type 1. Tm., tumor cell. ↑, increase; ↓, decrease; –, non tested. Black and red arrows denote in vitro and in vivo data, respectively.